Prolonged glucosuria and relapse of diabetic ketoacidosis related to SGLT2-inhibitor therapy

SGLT2 inhibitors (SGLT2i) are glucose-lowering medications which increase the renal threshold for glucose reabsorption and promote glucosuria. Treatment with these agents raises serum ketone levels, and cases of diabetic ketoacidosis (DKA) during therapy have been reported. The duration of glucosuri...

Full description

Saved in:
Bibliographic Details
Published inEndocrinology, diabetes & metabolism Vol. 3; no. 2; p. e00117
Main Authors Westcott, Gregory P, Segal, Alissa R, Mitri, Joanna, Brown, Florence M
Format Report
LanguageEnglish
Published 01.04.2020
Online AccessGet full text

Cover

More Information
Summary:SGLT2 inhibitors (SGLT2i) are glucose-lowering medications which increase the renal threshold for glucose reabsorption and promote glucosuria. Treatment with these agents raises serum ketone levels, and cases of diabetic ketoacidosis (DKA) during therapy have been reported. The duration of glucosuria and inpatient course of SGLT2i-related DKA, however, is not well-characterized. We report 11 inpatient cases of SGLT2i-related DKA, including a subset of patients who experienced prolonged glucosuria and relapse of DKA during their hospitalization.
Bibliography:ObjectType-Case Study-2
content type line 59
SourceType-Reports-1
ObjectType-Report-1
ISSN:2398-9238
DOI:10.1002/edm2.117